162 related articles for article (PubMed ID: 20110852)
21. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
22. Treatment of portal systemic encephalopathy: standard and new treatments.
Marín E; Uribe M
Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
[TBL] [Abstract][Full Text] [Related]
23. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.
Gerber T; Schomerus H
Drugs; 2000 Dec; 60(6):1353-70. PubMed ID: 11152016
[TBL] [Abstract][Full Text] [Related]
24. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy.
Plank LD; McCall JL; Gane EJ; Rafique M; Gillanders LK; McIlroy K; Munn SR
Clin Nutr; 2005 Apr; 24(2):288-96. PubMed ID: 15784491
[TBL] [Abstract][Full Text] [Related]
25. [On the treatment of hepatic coma].
Kommerell B
Dtsch Med J; 1968 Dec; 19(23):809-15. PubMed ID: 4886418
[No Abstract] [Full Text] [Related]
26. Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.
Teperman LW
Int J Hepatol; 2013; 2013():952828. PubMed ID: 24324895
[TBL] [Abstract][Full Text] [Related]
27. Review article: the current pharmacological therapies for hepatic encephalopathy.
Bass NM
Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():23-31. PubMed ID: 17295849
[TBL] [Abstract][Full Text] [Related]
28. Pretransplant status and patient survival following liver transplantation.
Eckhoff DE; Pirsch JD; D'Alessandro AM; Knechtle SJ; Young CJ; Geffner SR; Belzer FO; Kalayoglu M
Transplantation; 1995 Nov; 60(9):920-5. PubMed ID: 7491694
[TBL] [Abstract][Full Text] [Related]
29. Covert hepatic encephalopathy: not as minimal as you might think.
Kappus MR; Bajaj JS
Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1208-19. PubMed ID: 22728384
[TBL] [Abstract][Full Text] [Related]
30. Cyclic treatment of chronic hepatic encephalopathy with rifaximin. Results of a double-blind clinical study.
Loguercio C; Federico A; De Girolamo V; Ferrieri A; Del Vecchio Blanco C
Minerva Gastroenterol Dietol; 2003 Mar; 49(1):53-62. PubMed ID: 16481971
[TBL] [Abstract][Full Text] [Related]
31. Treatment guidelines for hepatic encephalopathy.
Thompson JR
Pharmacotherapy; 2010 May; 30(5 Pt 2):4S-9S. PubMed ID: 20412034
[TBL] [Abstract][Full Text] [Related]
32. Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy.
Hill K; Hu KQ; Cottrell A; Teichman S; Hillebrand DJ
Am J Gastroenterol; 2003 Dec; 98(12):2763-70. PubMed ID: 14687830
[TBL] [Abstract][Full Text] [Related]
33. Role of antibiotics in the management of hepatic encephalopathy.
Maddrey WC
Rev Gastroenterol Disord; 2005; 5 Suppl 1():S3-9. PubMed ID: 15976746
[TBL] [Abstract][Full Text] [Related]
34. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
Tapper EB; Jiang ZG; Patwardhan VR
Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
[TBL] [Abstract][Full Text] [Related]
35. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of chronic hepatic encephalopathy.
Seery JP; Aspinall RJ; Taylor-Robinson SD
Hosp Med; 1998 Mar; 59(3):200-4. PubMed ID: 9722346
[TBL] [Abstract][Full Text] [Related]
37. An evidence-based update on hepatic encephalopathy.
Abdo AA
Saudi J Gastroenterol; 2006; 12(1):8-15. PubMed ID: 19858578
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of post-hemorrhagic hepatic encephalopathy in patients with cirrhosis].
Doffoël M; Vetter D; Bockel R
Gastroenterol Clin Biol; 1990; 14(1 ( Pt 2)):29B-33B. PubMed ID: 1968870
[No Abstract] [Full Text] [Related]
39. Liver transplantation improves hepatic myelopathy: evidence by three cases.
Weissenborn K; Tietge UJ; Bokemeyer M; Mohammadi B; Bode U; Manns MP; Caselitz M
Gastroenterology; 2003 Feb; 124(2):346-51. PubMed ID: 12557140
[TBL] [Abstract][Full Text] [Related]
40. Recent insights into the pathogenesis of hepatic encephalopathy and treatments.
Sturgeon JP; Shawcross DL
Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):83-100. PubMed ID: 24236755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
